Evidence map›Paper›PMID 28794442›Full record

ArticleScientific reports2017

The Conserved Lysine-265 Allosterically Modulates Nucleotide- and Actin-binding Site Coupling in Myosin-2.

Vincent A Behrens, Stefan Münnich, Georg Adler-Gunzelmann, Claudia Thiel, Arnon Henn, Sharissa L Latham, Manuel H Taft

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phenamacril is a reversible and noncompetitive inhibitor ofThe Journal of biological chemistry · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Vincent A BehrensInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Stefan MünnichInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Georg Adler-GunzelmannInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Claudia ThielInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Arnon HennFaculty of Biology, Technion - Israel Institute of Technology, Haifa, 3200003, Israel.
Sharissa L LathamInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Manuel H TaftInstitute for Biophysical Chemistry, Hannover Medical School, OE 4350, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Taft.Manuel@MH-Hannover.de.ORCID 0000-0001-5853-8629
Medizinische Hochschule Hannover · DETechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myosin motor proteins convert chemical energy into force and movement through their interactions with nucleotide and filamentous actin (F-actin). The evolutionarily conserved lysine-265 (K265) of the myosin-2 motor from Dictyostelium discoideum (Dd) is proposed to be a key residue in an allosteric communication pathway that mediates actin-nucleotide coupling. To better understand the role of K265, point mutations were introduced within the Dd myosin-2 M765-2R framework, replacing this lysine with alanine (K265A), glutamic acid (K265E) or glutamine (K265Q), and the functional and kinetic properties of the resulting myosin motors were assessed. The alanine and glutamic acid substitutions reduced actin-activated ATPase activity, slowed the in vitro sliding velocity and attenuated the inhibitory potential of the allosteric myosin inhibitor pentabromopseudilin (PBP). However, glutamine substitution did not substantially change these parameters. Structural modelling suggests that K265 interacts with D590 and Q633 to establish a pivotal allosteric branching point. Based on our results, we propose: (1) that the K265-D590 interaction functions to reduce myosins basal ATPase activity in the absence of F-actin, and (2) that the dynamic formation of the K265-Q633 salt bridge upon actin cleft closure regulates the activation of product release by actin filaments.

Indexed as

Binding SitesActinsAdenosine DiphosphateAdenosine TriphosphatasesAdenosine TriphosphateAlanineAllosteric RegulationEnzyme ActivationGene ExpressionGlutamic AcidKineticsLysineModels, MolecularMutationMyosin Type IINucleotidesActinsAdenosine DiphosphateAdenosine TriphosphatasesAdenosine TriphosphateAlanineGlutamic AcidLysineMyosin Type IINucleotides

Identifiers

PMID28794442
PMCPMC5550493
OpenAlexW2743673878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.